Cite
MLA Citation
Feng-Cai Zhu et al.. “Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial.” Lancet, vol. 385, no. 9984, 2015, pp. 2272–2279. http://access.bl.uk/ark:/81055/vdc_100042266137.0x00004b